Alvimopan accelerates gastrointestinal recovery after radical cystectomy: A multicenter randomized placebo-controlled trial

European Urology

Volumn 66, Issue 2, 2014, Pages 265-272

  Lee, Cheryl T ^a   Chang, Sam S ^b   Kamat, Ashish M ^c   Amiel, Gilad ^d   Beard, Timothy L ^e   Fergany, Amr ^f   Karnes, R Jeffrey ^g   Kurz, Andrea ^f   Menon, Venu ^f   Sexton, Wade J ^h   Slaton, Joel W ⁱ   Svatek, Robert S ^j   Wilson, Shandra S ^k   Techner, Lee ^l   Bihrle, Richard ^m   Steinberg, Gary D ⁿ   Koch, Michael ^m  

^a UNIVERSITY OF MICHIGAN   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e Bend Memorial Clinic   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g MAYO CLINIC   (United States)

^h H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

ⁱ UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^k UNIVERSITY OF COLORADO   (United States)

^l CUBIST PHARMACEUTICALS INC   (United States)

^m INDIANA UNIVERSITY MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

more..

Author keywords

Alvimopan; Enhanced recovery pathway; Gastrointestinal recovery; Postoperative ileus; Radical cystectomy

Indexed keywords

ALVIMOPAN; OPIATE; PLACEBO; GASTROINTESTINAL AGENT; NARCOTIC ANALGESIC AGENT; PIPERIDINE DERIVATIVE;

AGED; ARTICLE; BLADDER CANCER; CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; DEEP VEIN THROMBOSIS; DEHYDRATION; DRUG EFFICACY; EPIDURAL ANESTHESIA; FEMALE; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INCIDENCE; LAPAROTOMY; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE ILEUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; CONVALESCENCE; DEFECATION; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; EATING; GASTROINTESTINAL TRACT; ILEUS; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; POSTOPERATIVE CARE; PROSPECTIVE STUDY; TIME;

AGED; ANALGESICS, OPIOID; CARDIOVASCULAR DISEASES; CYSTECTOMY; DEFECATION; DOUBLE-BLIND METHOD; EATING; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL TRACT; HUMANS; ILEUS; LENGTH OF STAY; MALE; MIDDLE AGED; PIPERIDINES; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 84904060930     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.02.036     Document Type: Article

References (30)

1. S.M. Donat, A. Shabsigh, and C. Savage et al. Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience Eur Urol 55 2009 177 186
2. S.M. Donat, T. Siegrist, and A. Cronin et al. Radical cystectomy in octogenarians - does morbidity outweigh the potential survival benefits? J Urol 183 2010 2171 2177
3. B.K. Hollenbeck, D.C. Miller, and D. Taub et al. Identifying risk factors for potentially avoidable complications following radical cystectomy J Urol 174 2005 1231 1237 discussion 1237
4. W.T. Lowrance, J.A. Rumohr, and S.S. Chang et al. Contemporary open radical cystectomy: analysis of perioperative outcomes J Urol 179 2008 1313 1318 discussion 1318
5. A. Shabsigh, R. Korets, and K.C. Vora et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology Eur Urol 55 2009 164 176
6. C.J. Stimson, S.S. Chang, and D.A. Barocas et al. Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series J Urol 184 2010 1296 1300
7. J.A. Ramirez, A.G. McIntosh, R. Strehlow, V.A. Lawrence, D.J. Parekh, and R.S. Svatek Definition, incidence, risk factors, and prevention of paralytic ileus following radical cystectomy: a systematic review Eur Urol 64 2013 588 597
8. S.S. Chang, R.G. Baumgartner, N. Wells, M.S. Cookson, and J.A. Smith Jr. Causes of increased hospital stay after radical cystectomy in a clinical pathway setting J Urol 167 2002 208 211
9. M.G. Doorly, and A.J. Senagore Pathogenesis and clinical and economic consequences of postoperative ileus Surg Clin North Am 92 2012 259 272 viii
10. S.S. Chang, M.S. Cookson, R.G. Baumgartner, N. Wells, and J.A. Smith Jr. Analysis of early complications after radical cystectomy: results of a collaborative care pathway J Urol 167 2002 2012 2016
11. M. Maffezzini, F. Campodonico, G. Canepa, G. Gerbi, and D. Parodi Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus Surg Oncol 17 2008 41 48
12. R.S. Pruthi, M. Nielsen, and A. Smith et al. Fast track program in patients undergoing radical cystectomy: results in 362 consecutive patients J Am Coll Surg 210 2010 93 99
13. M. Melnyk, R.G. Casey, P. Black, and A.J. Koupparis Enhanced Recovery After Surgery (ERAS) protocols: time to change practice? Can Urol Assoc J 5 2011 342 348
14. W.M. Hilton, Y. Lotan, D.J. Parekh, J.W. Basler, and R.S. Svatek Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost-effectiveness analysis BJU Int 111 2013 1054 1060
15. M.W. Buchler, C.M. Seiler, and J.R.T. Monson et al. Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study Aliment Pharmacol Ther 28 2008 312 325
16. C.P. Delaney, J.L. Weese, and N.H. Hyman et al. Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery Dis Colon Rectum 48 2005 1114 1125 discussion 1125-6; author reply 1127-9
17. K. Ludwig, W.E. Enker, and C.P. Delaney et al. Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway Arch Surg 143 2008 1098 1105
18. E.R. Viscusi, S. Goldstein, and T. Witkowski et al. Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study Surg Endosc 20 2006 64 70
19. B.G. Wolff, F. Michelassi, and T.M. Gerkin et al. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus Ann Surg 240 2004 728 734 discussion 734-5
20. Cubist Pharmaceuticals. Entereg (alvimopan) capsules: highlights of prescribing information. Entereg Web site. http://www.entereg.com/images/pdf/ entereg-prescribing-information.pdf. Accessed December 13, 2013.
21. A.A. Vora, A. Harbin, and R. Rayson et al. Alvimopan provides rapid gastrointestinal recovery without nasogastric tube decompression after radical cystectomy and urinary diversion Can J Urol 19 2012 6293 6298
22. R.S. Svatek, M.B. Fisher, and S.F. Matin et al. Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria J Urol 183 2010 929 934
23. C.P. Delaney, C. Craver, and M.M. Gibbons et al. Evaluation of clinical outcomes with alvimopan in clinical practice: a national matched-cohort study in patients undergoing bowel resection Ann Surg 255 2012 731 738
24. M. Adamina, H. Kehlet, G.A. Tomlinson, A.J. Senagore, and C.P. Delaney Enhanced recovery pathways optimize health outcomes and resource utilization: a meta-analysis of randomized controlled trials in colorectal surgery Surgery 149 2011 830 840
25. K. Lassen, M. Soop, and J. Nygren et al. Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) group recommendations Arch Surg 144 2009 961 969
26. B.W. Miedema, and J.O. Johnson Methods for decreasing postoperative gut dysmotility Lancet Oncol 4 2003 365 372
27. T.L. Kauf, R.S. Svatek, and G. Amiel et al. Alvimopan, a peripherally acting mu-opioid receptor antagonist, is associated with reduced costs after radical cystectomy - economic analysis of a phase 4 randomized, controlled trial J Urol 191 2014 1721 1727
28. F. Liedberg Early complications and morbidity of radical cystectomy Eur Urol Suppl 9 2010 25 30
29. B. Roth, F.D. Birkhäuser, P. Zehnder, F.C. Burkhard, G.N. Thalmann, and U.E. Studer Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a prospective randomized trial Eur Urol 59 2011 204 210
30. Y. Cerantola, M. Valerio, and B. Persson et al. Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS®) society recommendations Clin Nutr 32 2013 879 887